Nomura Securities Maintains a 'Buy' on Danaher (DHR); Premier, Through-the-Cycle Stock

June 19, 2012 8:41 AM EDT Send to a Friend
Get Alerts DHR Hot Sheet
Price: $64.07 +1.30%

Rating Summary:
    13 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 43 | New: 13
Trade DHR Now!
Nomura Securities maintains a 'Buy' on Danaher (NYSE: DHR) price target of $65.00.

Analyst, Shannon O’Callaghan, said, "Danaher’s success with AB SCIEX (acquired February 2010) demonstrates that the company knows how to win with Life Sciences instrument businesses. While recent cyclical pressures in Tek Instruments and Motion have driven investor criticism of organic growth (only 1.5% in 1Q), we view those dynamics as temporary. Since acquisition, AB SCIEX has seen significant improvements in organic growth, gross margins, operating margins, and new product development."

For an analyst ratings summary and ratings history on Danaher click here. For more ratings news on Danaher click here.

Shares of Danaher closed at $51.89 yesterday, with a 52 week range of $39.34-$56.45.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Nomura

Add Your Comment